These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 28606106)

  • 41. Timely measles vaccination in Tianjin, China: a cross-sectional study of immunization records and mothers.
    Wagner AL; Zhang Y; Montgomery JP; Ding Y; Carlson BF; Boulton ML
    BMC Public Health; 2014 Aug; 14():888. PubMed ID: 25168663
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Changes in the pneumococcal disease-related hospitalisations in Spain after the replacement of 7-valent by 13-valent conjugate vaccine.
    Georgalis L; Mozalevskis A; Martínez de Aragón MV; Garrido-Estepa M
    Eur J Clin Microbiol Infect Dis; 2017 Mar; 36(3):575-583. PubMed ID: 27844262
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Declines in Pneumonia and Meningitis Hospitalizations in Children Under 5 Years of Age After Introduction of 10-Valent Pneumococcal Conjugate Vaccine in Zambia, 2010-2016.
    Mpabalwani EM; Lukwesa-Musyani C; Imamba A; Nakazwe R; Matapo B; Muzongwe CM; Mufune T; Soda E; Mwenda JM; Lutz CS; Pondo T; Lessa FC
    Clin Infect Dis; 2019 Sep; 69(Suppl 2):S58-S65. PubMed ID: 31505628
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparative effectiveness of individual pneumococcal vaccines with dual pneumococcal vaccination in older United States Veterans.
    Narsingam S; Munson J; Drescher F
    Vaccine; 2022 Aug; 40(35):5223-5228. PubMed ID: 35927134
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cost-effectiveness of a pneumococcal conjugate immunisation program for infants in Switzerland.
    Ess SM; Schaad UB; Gervaix A; Pinösch S; Szucs TD
    Vaccine; 2003 Jul; 21(23):3273-81. PubMed ID: 12804858
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Knowledge, attitude, and practice regarding infection and vaccination in patients with rheumatic diseases in China.
    Jiang Y; Zhang X; Lv Q; Qi J; Guo X; Wei Q; Liao Z; Lin Z; Gu J
    Hum Vaccin Immunother; 2019; 15(5):1100-1105. PubMed ID: 30689509
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The impact of childhood pneumococcal vaccination on hospital admissions in England: a whole population observational study.
    Shiri T; McCarthy ND; Petrou S
    BMC Infect Dis; 2019 Jun; 19(1):510. PubMed ID: 31182036
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Burden of invasive pneumococcal disease (IPD) in Sri-Lanka: Deriving a reasonable measure for vaccine introduction decision making.
    Kularatna S; Wijesinghe PR; Abeysinghe MR; Karunaratne K; Ekanayake L
    Vaccine; 2015 Jun; 33(27):3122-8. PubMed ID: 25976543
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The impact of 7-valent pneumococcal conjugate vaccine on invasive pneumococcal disease: a literature review.
    Myint TT; Madhava H; Balmer P; Christopoulou D; Attal S; Menegas D; Sprenger R; Bonnet E
    Adv Ther; 2013 Feb; 30(2):127-51. PubMed ID: 23397399
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Economic burden of pneumococcal infections in children under 5 years of age.
    Ceyhan M; Ozsurekci Y; Aykac K; Hacibedel B; Ozbilgili E
    Hum Vaccin Immunother; 2018 Jan; 14(1):106-110. PubMed ID: 28922054
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Modelling the effect of conjugate vaccines in pneumococcal disease: cohort or population models?
    Standaert B; Demarteau N; Talbird S; Mauskopf J
    Vaccine; 2010 Nov; 28 Suppl 6():G30-8. PubMed ID: 21075268
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pneumococcal conjugate vaccine for young children.
    Selman S; Hayes D; Perin LA; Hayes WS
    Manag Care; 2000 Sep; 9(9):49-52, 54, 56-7 passim. PubMed ID: 11116663
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pediatric hospitalization for pneumococcal diseases preventable by 7-valent pneumococcal conjugate vaccine in Hong Kong.
    Ho PL; Chiu SS; Chow FK; Mak GC; Lau YL
    Vaccine; 2007 Sep; 25(39-40):6837-41. PubMed ID: 17714837
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The cost-burden of paediatric pneumococcal disease in Sweden and the potential cost-effectiveness of prevention using 7-valent pneumococcal vaccine.
    Silfverdal SA; Berg S; Hemlin C; Jokinen I
    Vaccine; 2009 Mar; 27(10):1601-8. PubMed ID: 19146905
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Measles containing vaccine coverage and factors associated with its uptake among children aged 24-59 months in Cherangany Sub County, Trans Nzoia County, Kenya.
    Mamuti S; Tabu C; Marete I; Opili D; Jalang'o R; Abade A
    PLoS One; 2022; 17(2):e0263780. PubMed ID: 35196355
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of the antipneumococcal conjugate vaccine on the occurrence of infectious respiratory diseases and hospitalization rates in children.
    Abrão WM; Mello LM; Silva AS; Nunes AA
    Rev Soc Bras Med Trop; 2015; 48(1):44-9. PubMed ID: 25860463
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical and bacteriological characteristics of invasive pneumococcal disease after pneumococcal 10-valent conjugate vaccine implementation in Salvador, Brazil.
    Leite CR; Azevedo J; Galvão VS; Moreno-Carvalho O; Reis JN; Nascimento-Carvalho C
    Braz J Infect Dis; 2016; 20(1):56-60. PubMed ID: 26706019
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pneumococcal conjugate vaccines: epidemiology guides clinical use.
    Heininger U
    Klin Padiatr; 2011 Mar; 223(2):59-60. PubMed ID: 21432762
    [No Abstract]   [Full Text] [Related]  

  • 59. Surveillance of impact of PCV-10 vaccine on pneumococcal meningitis in Mozambique, 2013 - 2015.
    Nhantumbo AA; Weldegebriel G; Katsande R; de Gouveia L; Comé CE; Cuco AZ; Cantarelli VV; Dias C; Caierão J; Mathiu JM; Gudo ES
    PLoS One; 2017; 12(6):e0177746. PubMed ID: 28604773
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of 10- and 13-valent pneumococcal conjugate vaccines on incidence of invasive pneumococcal disease in children aged under 16 years in Germany, 2009 to 2012.
    Weiss S; Falkenhorst G; van der Linden M; Imohl M; von Kries R
    Euro Surveill; 2015 Mar; 20(10):21057. PubMed ID: 25788255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.